H.C. Wainwright adjusted the firm’s price target on Acurx (ACXP) to $31 from $8 and keeps a Buy rating on the shares following the recent 1-for-20 reverse stock split. The firm believes the company’s lead asset ibezapolstat is making steady progress as it prepares to enter Phase 3 evaluation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACXP: